Thomas Hudson
Chief Tech/Sci/R&D Officer bei ABBVIE INC.
Vermögen: 20 Mio $ am 31.03.2024
Profil
Gründer der McGill University & Gnome Qubec Innovation Centre, Thomas J. Hudson ist Chief Scientific Officer, Senior VP-R&D bei AbbVie, Inc. Er ist außerdem wissenschaftlicher Direktor beim P3G Consortium und Professor an der Universität von Toronto. In der Vergangenheit war er Präsident und wissenschaftlicher Direktor am Ontario Institute for Cancer Research, stellvertretender Direktor des Zentrums für Genomforschung am Whitehead Institute for Biomedical Research und Direktor an der McGill University & Gnome Qubec Innovation Centre.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ABBVIE, INC.
0,01% | 28.02.2024 | 107 267 ( 0,01% ) | 20 Mio $ | 31.03.2024 |
Aktive Positionen von Thomas Hudson
| Unternehmen | Position | Beginn |
|---|---|---|
| ABBVIE INC. | Chief Tech/Sci/R&D Officer | 01.07.2019 |
| University of Toronto | Corporate Officer/Principal | 01.01.2007 |
| P3G Consortium | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Thomas Hudson
| Unternehmen | Position | Ende |
|---|---|---|
Ontario Institute for Cancer Research
 Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | President | 01.01.2016 |
| McGill University & Génome Québec Innovation Centre | Founder | 01.01.2011 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2001 |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Ausbildung von Thomas Hudson
| University of Montréal | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABBVIE INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Ontario Institute for Cancer Research
Ontario Institute for Cancer Research Hospital/Nursing ManagementHealth Services Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada. | Health Services |
| P3G Consortium |
